| Antipsychotics - Clozapine (GP information) |
April 2022 |
March 2025 |
| Antipsychotics - Prescribing and Management for mental health conditions |
October 2022 |
September 2025 |
| Chloral Hydrate position statement |
February 2022 |
January 2025 |
| Dementia - management in primary care |
February 2022 |
January 2025 |
| Dementia - managing behavioural problems |
April 2023 |
March 2026 |
| Depression and the use of antidepressants |
October 2022 |
September 2025 |
| Domperidone - off licence use |
April 2020 |
March 2023 |
| Melatonin - for the treatment of sleep disorders in children |
March 2022 |
February 2025 |
| Metoclopramide use in gastro-paresis |
May 2023 |
April 2026 |
| Midazolam - management of convulsive seizures in the community |
June 2020 |
May 2023 |
| Pain - Deprescribing and safer prescribing of strong opioids in non malignant pain |
October 2021 |
September 2024 |
| Pain - Nefopam (position statement) |
October 2021 |
September 2024 |
| Pain - neuropathic pain in primary care |
April 2023 |
March 2026 |
| Pain - non-malignant chronic pain in primary care |
October 2021 |
September 2024 |
| Pain - opioids - choice of strong opioids for cancer pain |
October 2021 |
September 2024 |
| Sativex - for severe spasticity in multiple sclerosis |
September 2022 |
August 2025 |
| Smoking cessation - NRT formulary |
February 2023 |
January 2026 |
